Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta

Chemokine CX3CL1 is unique, possessing the ability to act as a dual agent: chemoattractant and adhesive compound. Acting via its sole receptor CX3CR1, CX3CL1 participates in many processes in human placental tissue, including inflammation and angiogenesis. Strongly upregulated by hypoxia and/or infl...

Full description

Saved in:
Bibliographic Details
Main Authors: Dariusz Szukiewicz, Jan Kochanowski, Michal Pyzlak, Grzegorz Szewczyk, Aleksandra Stangret, Tarun Kumar Mittal
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/437576
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849414204328509440
author Dariusz Szukiewicz
Jan Kochanowski
Michal Pyzlak
Grzegorz Szewczyk
Aleksandra Stangret
Tarun Kumar Mittal
author_facet Dariusz Szukiewicz
Jan Kochanowski
Michal Pyzlak
Grzegorz Szewczyk
Aleksandra Stangret
Tarun Kumar Mittal
author_sort Dariusz Szukiewicz
collection DOAJ
description Chemokine CX3CL1 is unique, possessing the ability to act as a dual agent: chemoattractant and adhesive compound. Acting via its sole receptor CX3CR1, CX3CL1 participates in many processes in human placental tissue, including inflammation and angiogenesis. Strongly upregulated by hypoxia and/or inflammation-induced inflammatory cytokines secretion, CX3CL1 may act locally as a key angiogenic factor. Both clinical observations and histopathological studies of the diabetic placenta have confirmed an increased incidence of hypoxia and inflammatory reactions with defective angiogenesis. In this study we examined comparatively (diabetes class C complicated versus normal pregnancy) the correlation between CX3CL1 content in placental tissue, the mean CX3CR1 expression, and density of the network of placental microvessels. A sandwich enzyme immunoassay was applied for CX3CL1 measurement in placental tissue homogenates, whereas quantitative immunohistochemical techniques were used for the assessment of CX3CR1 expression and the microvascular density. Significant differences have been observed for all analyzed parameters between the groups. The mean concentration of CX3CL1 in diabetes was increased and accompanied by augmented placental microvessel density as well as a higher expression of CX3CR1. In conclusion, we suggest involvement of CX3CL1/CX3CR1 signaling pathway in the pathomechanism of placental microvasculature remodeling in diabetes class C.
format Article
id doaj-art-6df32e2b53ca408eb83c50be9bc56f9f
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-6df32e2b53ca408eb83c50be9bc56f9f2025-08-20T03:33:54ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/437576437576Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic PlacentaDariusz Szukiewicz0Jan Kochanowski1Michal Pyzlak2Grzegorz Szewczyk3Aleksandra Stangret4Tarun Kumar Mittal5Department of General & Experimental Pathology, Second Faculty of Medicine, Medical University of Warsaw, Ulica Krakowskie Przedmiescie 26/28, 00-928 Warsaw, PolandDepartment of Neurology, Second Faculty of Medicine, Medical University of Warsaw, Ulica Ceglowska 80, 01-809 Warsaw, PolandDepartment of General & Experimental Pathology, Second Faculty of Medicine, Medical University of Warsaw, Ulica Krakowskie Przedmiescie 26/28, 00-928 Warsaw, PolandDepartment of General & Experimental Pathology, Second Faculty of Medicine, Medical University of Warsaw, Ulica Krakowskie Przedmiescie 26/28, 00-928 Warsaw, PolandDepartment of General & Experimental Pathology, Second Faculty of Medicine, Medical University of Warsaw, Ulica Krakowskie Przedmiescie 26/28, 00-928 Warsaw, PolandDepartment of Obstetrics & Gynecology, Second Faculty of Medicine, Medical University of Warsaw, Ulica Kondratowicza 8, 03-242 Warsaw, PolandChemokine CX3CL1 is unique, possessing the ability to act as a dual agent: chemoattractant and adhesive compound. Acting via its sole receptor CX3CR1, CX3CL1 participates in many processes in human placental tissue, including inflammation and angiogenesis. Strongly upregulated by hypoxia and/or inflammation-induced inflammatory cytokines secretion, CX3CL1 may act locally as a key angiogenic factor. Both clinical observations and histopathological studies of the diabetic placenta have confirmed an increased incidence of hypoxia and inflammatory reactions with defective angiogenesis. In this study we examined comparatively (diabetes class C complicated versus normal pregnancy) the correlation between CX3CL1 content in placental tissue, the mean CX3CR1 expression, and density of the network of placental microvessels. A sandwich enzyme immunoassay was applied for CX3CL1 measurement in placental tissue homogenates, whereas quantitative immunohistochemical techniques were used for the assessment of CX3CR1 expression and the microvascular density. Significant differences have been observed for all analyzed parameters between the groups. The mean concentration of CX3CL1 in diabetes was increased and accompanied by augmented placental microvessel density as well as a higher expression of CX3CR1. In conclusion, we suggest involvement of CX3CL1/CX3CR1 signaling pathway in the pathomechanism of placental microvasculature remodeling in diabetes class C.http://dx.doi.org/10.1155/2013/437576
spellingShingle Dariusz Szukiewicz
Jan Kochanowski
Michal Pyzlak
Grzegorz Szewczyk
Aleksandra Stangret
Tarun Kumar Mittal
Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
Mediators of Inflammation
title Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
title_full Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
title_fullStr Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
title_full_unstemmed Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
title_short Fractalkine (CX3CL1) and Its Receptor CX3CR1 May Contribute to Increased Angiogenesis in Diabetic Placenta
title_sort fractalkine cx3cl1 and its receptor cx3cr1 may contribute to increased angiogenesis in diabetic placenta
url http://dx.doi.org/10.1155/2013/437576
work_keys_str_mv AT dariuszszukiewicz fractalkinecx3cl1anditsreceptorcx3cr1maycontributetoincreasedangiogenesisindiabeticplacenta
AT jankochanowski fractalkinecx3cl1anditsreceptorcx3cr1maycontributetoincreasedangiogenesisindiabeticplacenta
AT michalpyzlak fractalkinecx3cl1anditsreceptorcx3cr1maycontributetoincreasedangiogenesisindiabeticplacenta
AT grzegorzszewczyk fractalkinecx3cl1anditsreceptorcx3cr1maycontributetoincreasedangiogenesisindiabeticplacenta
AT aleksandrastangret fractalkinecx3cl1anditsreceptorcx3cr1maycontributetoincreasedangiogenesisindiabeticplacenta
AT tarunkumarmittal fractalkinecx3cl1anditsreceptorcx3cr1maycontributetoincreasedangiogenesisindiabeticplacenta